Norgestrel
From Wikipedia, the free encyclopedia
Norgestrel
|
|
Systematic (IUPAC) name | |
(8R,9S,10R,13S,14S,17S)- 13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,14,15, 16- dodecahydrocyclopenta[a]phenanthren-3-one | |
Identifiers | |
CAS number | 6533-00-2 |
ATC code | G03AC03 |
PubChem | 13109 |
DrugBank | APRD00106 |
Chemical data | |
Formula | C21H28O2 |
Mol. weight | 312.446 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | 5-14 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Norgestrel is a progestin used in hormonal contraceptives. Norgestrel is a mixture of two stereoisomers, dextro-norgestrel and levo-norgestrel. Only levonorgestrel is biologically active. Therefore, while some medications may contain dextronorgestrel, they are often labeled in terms of their levonorgestrel content only, ignoring the inert isomer.